MANGOCEUTICALS, INC. financial data

Symbol
MGRX on Nasdaq
Location
Dallas, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 18.2 % -50.8%
Quick Ratio 1.44 %
Debt-to-equity 7.71 % -52%
Return On Equity -115 % +15.6%
Return On Assets -106 % +10.5%
Operating Margin -4.14K % -253%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.9M shares +459%
Common Stock, Shares, Outstanding 13.9M shares +550%
Entity Public Float 5.86M USD -56.4%
Common Stock, Value, Issued 1.39K USD +552%
Weighted Average Number of Shares Outstanding, Basic 11.5M shares +472%
Weighted Average Number of Shares Outstanding, Diluted 11.5M shares +472%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 467K USD -38.2%
Cost of Revenue 67.2K USD -46.3%
General and Administrative Expense 3.95M USD -6.41%
Operating Income (Loss) -19.3M USD -118%
Nonoperating Income (Expense) -75.9K USD +68.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.8M USD -113%
Net Income (Loss) Attributable to Parent -19.8M USD -113%
Earnings Per Share, Basic -3 USD/shares +67.9%
Earnings Per Share, Diluted -3 USD/shares +67.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 481K USD +551%
Inventory, Net 13.2K USD -38.8%
Assets, Current 598K USD +475%
Property, Plant and Equipment, Net 2.05K USD -33.1%
Operating Lease, Right-of-Use Asset 11.2K USD -85%
Intangible Assets, Net (Excluding Goodwill) 15.9M USD +8.97%
Assets 16.5M USD +11.8%
Liabilities, Current 804K USD -42.2%
Operating Lease, Liability, Noncurrent 12.2K USD -85.1%
Liabilities 804K USD -42.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.08K USD -25%
Retained Earnings (Accumulated Deficit) -37.9M USD -111%
Stockholders' Equity Attributable to Parent 15.7M USD +17.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 15.7M USD +13.7%
Liabilities and Equity 16.5M USD +11.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.27M USD -130%
Net Cash Provided by (Used in) Financing Activities 2.29M USD +754%
Net Cash Provided by (Used in) Investing Activities -3.52K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 13.9M shares +550%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.11M USD +9834%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 481K USD +551%
Deferred Tax Assets, Valuation Allowance 4.03M USD +82.9%
Deferred Tax Assets, Gross 4.03M USD +82.9%
Operating Lease, Liability 12.2K USD -85.1%
Depreciation 250 USD -96%
Payments to Acquire Property, Plant, and Equipment 3.52K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.8M USD -113%
Lessee, Operating Lease, Liability, to be Paid 12.3K USD -85.7%
Operating Lease, Liability, Current 12.2K USD -82.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 67.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 67.6K USD -5.76%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 122 USD -97.1%
Deferred Tax Assets, Operating Loss Carryforwards 3.08M USD +75.9%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 53.3M USD +68.7%
Amortization of Intangible Assets 277K USD
Depreciation, Depletion and Amortization 250 USD -96%
Share-based Payment Arrangement, Expense 51K USD +34.3%
Interest Expense 1.76K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%